CKDXFOTCBiological Products, (No Diagnostic Substances)Fiscal year ends June 30Also trades as CYVNY
Opthea Ltd
Financials through fiscal 2025, year ended Jun 30, 2025Last filing: 20-F on Sep 15, 2025
$0.01+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Opthea statistics
Financials through Jun 30, 2025, price as of Oct 19, 2026, median of Biological Products, (No Diagnostic Substances) companies for comparison
Valuation
| Measure | Opthea | Industry median |
|---|---|---|
| Market Cap | $1.56M | $166.30M |
| Enterprise Value | -$37.15M | $88.19M |
| PS Ratio | 62.21 | 3.65 |
Enterprise value
| Measure | Opthea | Industry median |
|---|---|---|
| EV / Sales | -1486.07 | 2.51 |
Income (trailing twelve months)
| Measure | Opthea | Industry median |
|---|---|---|
| Revenue | $25.00K | $58.34M |
| Operating Income | -$155.76M | -$21.40M |
| Pretax Income | -$169.74M | -$14.34M |
| Net Income | -$162.79M | -$22.46M |
| EBITDA | -$155.76M | -$16.91M |
| EPS (Diluted) | -$0.13 | -$0.83 |
Margins
| Measure | Opthea | Industry median |
|---|---|---|
| Operating Margin | -623048.0% | -44.0% |
| Pretax Margin | -678952.0% | -13.3% |
| Profit Margin | -651164.0% | -40.2% |
| EBITDA Margin | -623020.0% | -30.2% |
| FCF Margin | -634628.0% | -9.27% |
Returns
| Measure | Opthea | Industry median |
|---|---|---|
| Return on Assets (ROA) | -286.6% | -40.9% |
Growth
| Measure | Opthea | Industry median |
|---|---|---|
| Revenue Growth (YoY) | -80.0% | 5.96% |
| Revenue Growth (3Y CAGR) | -34.9% | 2.25% |
| Revenue Growth (5Y CAGR) | -15.8% | 6.48% |
Balance sheet
| Measure | Opthea | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $48.44M | $61.43M |
| Total Debt | $9.74M | $118.52M |
| Net Cash (Debt) | $38.71M | $15.35M |
| Net Cash Per Share | $0.03 | $0.66 |
| Working Capital | -$201.07M | $76.81M |
Financial position
| Measure | Opthea | Industry median |
|---|---|---|
| Current Ratio | 0.22 | 3.34 |
| Quick Ratio | 0.19 | 2.44 |
| Interest Coverage | -19470.30 | -6.26 |
Cash flow (trailing twelve months)
| Measure | Opthea | Industry median |
|---|---|---|
| Operating Cash Flow | -$158.64M | -$12.35M |
| Capital Expenditures | -$13.00K | -$1.08M |
| Free Cash Flow | -$158.66M | -$20.22M |
| FCF Per Share | -$0.13 | -$0.42 |
Efficiency
| Measure | Opthea | Industry median |
|---|---|---|
| Asset Turnover | 0.00 | 0.39 |
| Revenue Per Employee | $6.25K | $404.87K |
| Profits Per Employee | -$40.70M | -$703.34K |
| Employee Count | 4 | 74 |
Dividends and yields
| Measure | Opthea | Industry median |
|---|---|---|
| Earnings Yield | -10466.8% | -23.3% |
| FCF Yield | -10201.0% | -8.72% |
Shares
| Measure | Opthea | Industry median |
|---|---|---|
| Shares Outstanding | 1,244,250,000 | 58,127,000 |
| Shares Change (YoY) | 91.9% | 10.9% |
| Float | 1,244,250,000 | 49,136,700 |
| Shares Held by Insiders | 0.00% | 11.6% |
Taxes
| Measure | Opthea | Industry median |
|---|---|---|
| Income Tax | -$6.95M | $79.87K |
Scores
| Measure | Opthea | Industry median |
|---|---|---|
| Altman Z-Score | -31.59 | -0.22 |
| Piotroski F-Score | 2 | 4 |
Calculated by StockData from Opthea's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.